FGF19 and gestational diabetes: The purpose of this study was to investigate the relationships between serum biomarkers Orexin A, PBP4, FGF19, and insulin resistance as measured by HOMA-IR, and neonatal weight in patients with gestational diabetes mellitus (GDM).